Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-04-22

FDA Approved: CIMZIA — Original Application (UCB, Inc.)

View source ↗

Summary

The FDA approved Cimzia (certolizumab pegol) in its original Biologics License Application, marking its initial approval for Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

ORIG AP for CIMZIA (CERTOLIZUMAB PEGOL)